13F-HR filed by UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO filed this 13F-HR for the quarter ended 2017-06-30, filed 2017-08-03, with 24 holding rows worth $33,640,000.
- Accession
- 0001019231-17-000005
- Filer
- CIK 1019231
- Filed
- 2017-08-03
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q2 2017
A holdings report, 24 entries on the cover page, a total value of $33,640,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $33,640,000 with VALUE read as thousands by filing date, 13F file number 028-05714. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WILLIAMS PARTNERS L P NEW | 96949L105 | COM UNIT LTD PAR | 172,732 | $6,928,000 | thousands by filing date | |
| Vanguard FTSE Developed Markets ETF | 921943858 | SHS | 82,592 | $3,413,000 | thousands by filing date | |
| Vanguard S&P 500 ETF | 922908363 | COM | 13,695 | $3,041,000 | thousands by filing date | |
| Vanguard Mid-Cap Value ETF | 922908512 | SHS | 29,172 | $3,001,000 | thousands by filing date | |
| VWO | 922042858 | SHS | 64,329 | $2,627,000 | thousands by filing date | |
| Texas Instruments Incorporated | 882508104 | COM | 32,000 | $2,462,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 524,929 | $2,021,000 | thousands by filing date | |
| BIO PATH HOLDINGS INC | 09057N102 | COM | 3,830,882 | $1,456,000 | thousands by filing date | |
| MIRAGEN THERAPEUTICS INC | 60463E103 | COM | 105,465 | $1,364,000 | thousands by filing date | |
| APOLLO ENDOSURGERY INC | 03767D108 | COM | 154,301 | $1,217,000 | thousands by filing date | |
| EXXON MOBIL CORP | 30231G102 | COM | 14,000 | $1,130,000 | thousands by filing date | |
| GENERAL MOLY INC COM | 370373102 | Common Stock | 2,922,831 | $1,080,000 | thousands by filing date | |
| Vanguard Energy ETF | 92204A306 | SHS | 10,260 | $908,000 | thousands by filing date | |
| Vanguard Real Estate | 922908553 | SHS | 9,189 | $765,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 35,714 | $587,000 | thousands by filing date | |
| GLOBAL BLOOD THERAPEUTICS USD | 37890U108 | COM | 17,800 | $487,000 | thousands by filing date | |
| JOUNCE THERAPEUTICS INC | 481116101 | COM | 30,488 | $428,000 | thousands by filing date | |
| PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23 | 72942A107 | COMMON STOCK | 62,673 | $385,000 | thousands by filing date | |
| PARK HOTELS & RESORTS INC COM | 700517105 | REIT | 9,587 | $258,000 | thousands by filing date | |
| MONSANTO CO NEW | 61166W101 | COM | 515 | $61,000 | thousands by filing date | |
| DISCOVERY INC | 25470F302 | COM SER C | 290 | $7,000 | thousands by filing date | |
| Johnson & Johnson | 478160104 | COM | 47 | $6,000 | thousands by filing date | |
| PORTLAND GEN ELEC CO | 736508847 | COM NEW | 118 | $5,000 | thousands by filing date | |
| DISCOVERY INC | 25470F104 | COM SER A | 115 | $3,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001019231-17-000005 | this filing | 2017-08-03 | acceptance time not in the bulk data set |